Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/8/2026

Simultaneous Administration of MMR, Varicella, and Hepatitis B Vaccines

Guideline Recommendations (Advisory Committee on Immunization Practices – ACIP)

Practical Implementation

Injection Technique

Visit Logistics

Documentation & Scheduling

Special Populations

All bullet points are derived from ACIP (Advisory Committee on Immunization Practices) recommendations and associated evidence cited in the referenced MMWR reports.

Simultaneous Administration of Multiple Pediatric Vaccines

Guideline Recommendations (Advisory Committee on Immunization Practices)

Immunologic Safety and Efficacy

Public Health Impact

Implementation Considerations

Critical Situations for Co‑Administration (ACIP)

Strength of Evidence

Concomitant Administration of MMR and Pneumococcal Conjugate Vaccines

ACIP Recommendations

  • The Advisory Committee on Immunization Practices (ACIP) recommends that the measles‑mumps‑rubella (MMR) vaccine be administered on the same day as any pneumococcal conjugate vaccine (PCV13‑Prevnar or PCV7), provided each is given at a separate anatomic site. This recommendation is based on high‑quality clinical trial data showing no immune interference or increased adverse events. 15

Administration Technique

  • Separate injection sites and syringes must be used for each vaccine when they are given concomitantly; vaccines should never be mixed in the same syringe unless an FDA‑approved combination product exists. This procedural guidance is part of the ACIP guideline. 16

Spacing Rules for Live and Inactivated Vaccines

  • If a live vaccine (e.g., MMR) is not given together with an inactivated vaccine, it must be spaced at least 4 weeks (28 days) from another live vaccine. Because Prevnar is an inactivated vaccine, this 4‑week interval does not apply to the MMR‑Prevnar combination. 17

Vaccine Interchangeability

  • Vaccines from different manufacturers are considered interchangeable; the lack of manufacturer information should not delay vaccination. The ACIP guideline explicitly states that unknown manufacturer does not constitute a contraindication. 15